Emmanouel M. Theodorakis

Emmanouel M. Theodorakis

Auto-generated profile, based on publicly available information

Emmanouel M. Theodorakis

Laboratory of Intensive Care Medicine, School of Medicine, University of Crete, Heraklion, 71003 Crete, Greece

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
EIEleftheria Ieronymaki
Eleftheria Ieronymaki
ETEmmanouel M. Theodorakis
Emmanouel M. Theodorakis
KLKonstantina Lyroni
Konstantina Lyroni
Eleni VergadiEleni Vergadi
Eleni Vergadi
ELEleni Lagoudaki
Eleni Lagoudaki
CTChristos Tsatsanis
Christos Tsatsanis
Obesity and insulin resistance influences metabolic processes, but whether it affects macrophage metabolism is not known. In this study, we demonstrate that chronic exposure of macrophages to insulin either in culture or in vivo in diet-induced, glucose-intolerant mice rendered them resistant to insulin signals marked by failure to induce Akt2 phosphorylation. Similarly, macrophages lacking Akt2 or IGF1 receptor were also resistant to insulin signals. Insulin-resistant macrophages had increased basal mTORC1 activity, possessed an M2-like phenotype, and reduced LPS responses. Moreover, they exhibited increased glycolysis and increased expression of key glycolytic enzymes. Inhibition of mTORC1 reversed the M2-like phenotype and suppressed glycolysis in insulin-resistant macrophages. In the context of polymicrobial sepsis, mice harboring insulin-resistant macrophages exhibited reduced sepsis-induced lung injury. Thus, macrophages obtain resistance to insulin characterized by increased glycolysis and a unique M2-like phenotype, termed M-insulin resistant, which accounts for obesity-related changes in macrophage responses and a state of trained immunity.